RxDoctor Payments Data

Mark Wittry, MD

Nuclear Medicine · Saint Louis, MONPI 1497721088

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,238 of the $4,542 with a category attached, or 71.3%. 29 manufacturers reported payments, led by Telix Pharmaceuticals at 38.6% of the total. Reporting peaked in 2024 at $2,446 and has fallen 88.2% since, to $289 in 2025.

$4,542in general payments, 2019–2025

Across 73 payments — averaging $62.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Telix Pharmaceuticals$2K
  • Edwards Lifesciences$719
  • Heartflow, Inc.$257
  • Progenics Pharmaceuticals, Inc.$221
  • AstraZeneca$191
  • Blue Earth Diagnostics$184
  • plus $1K from 23 others

What the payments were for

  • Travel & lodging$1,30429%
  • Food & beverage$3,23871%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,542 in reported general payments places this provider in the 80th percentile of 21 nuclear medicine providers in Missouri.

See all nuclear medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$154,845
Medicare patients
3,918
Services billed
4,192

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nuclear medicine in Saint Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →